---
figid: PMC8942669__OMCL2022-6023710.003
figtitle: Histone Methylation and Oxidative Stress in Cardiovascular Diseases
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8942669
filename: OMCL2022-6023710.003.jpg
figlink: /pmc/articles/PMC8942669/figure/fig3/
number: F3
caption: 'Histone methylation modulates oxidative stress in diabetic endothelial dysfunction
  and vascular complications. High levels of MMP-9 and TxnIP due to upregulation by
  LSD1 and EZH2 increase ROS overproduction in diabetic microvascular pathology. The
  expression and activity of Mn-SOD are decreased by both SUV420h2 and LSD1 in diabetic
  retinopathy. The Nrf2/Keap1 signaling pathway eliminates ROS in diabetic patients
  with retinopathy. KDM5A and SET7/9 both modulate the Nrf2/Keap1 signaling pathway
  and thus influence GSH biosynthesis (COX2: cyclooxygenase-2; EZH2: enhancer of zeste
  homolog 2; GSH: glutathione; Keap1: Kelch-like ECH-associated protein 1; KDM5A:
  lysine demethylase 5A; LSD1: lysine-specific demethylase 1; MMP-9: matrix metalloproteinase-9;
  NOX4: NADPH oxidase 4; ROS: reactive oxygen species; SET7/9: (su(var)-3-9,enhancer-of-zeste,trithorax)
  domain-containing protein 7/9; SOD3: superoxide dismutase 3; SP-1: specificity protein-1;
  SUV39H1: suppressor of variegation 3-9 homolog 1; SUV420H2: suppressor of variegation
  4-20 homolog 2; TxnIP: thioredoxin-interacting protein).'
papertitle: Histone Methylation and Oxidative Stress in Cardiovascular Diseases.
reftext: Xin Yi, et al. Oxid Med Cell Longev. 2022;2022:6023710.
year: '2022'
doi: 10.1155/2022/6023710
journal_title: Oxidative Medicine and Cellular Longevity
journal_nlm_ta: Oxid Med Cell Longev
publisher_name: Hindawi
keywords: ''
automl_pathway: 0.8430585
figid_alias: PMC8942669__F3
figtype: Figure
redirect_from: /figures/PMC8942669__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8942669__OMCL2022-6023710.003.html
  '@type': Dataset
  description: 'Histone methylation modulates oxidative stress in diabetic endothelial
    dysfunction and vascular complications. High levels of MMP-9 and TxnIP due to
    upregulation by LSD1 and EZH2 increase ROS overproduction in diabetic microvascular
    pathology. The expression and activity of Mn-SOD are decreased by both SUV420h2
    and LSD1 in diabetic retinopathy. The Nrf2/Keap1 signaling pathway eliminates
    ROS in diabetic patients with retinopathy. KDM5A and SET7/9 both modulate the
    Nrf2/Keap1 signaling pathway and thus influence GSH biosynthesis (COX2: cyclooxygenase-2;
    EZH2: enhancer of zeste homolog 2; GSH: glutathione; Keap1: Kelch-like ECH-associated
    protein 1; KDM5A: lysine demethylase 5A; LSD1: lysine-specific demethylase 1;
    MMP-9: matrix metalloproteinase-9; NOX4: NADPH oxidase 4; ROS: reactive oxygen
    species; SET7/9: (su(var)-3-9,enhancer-of-zeste,trithorax) domain-containing protein
    7/9; SOD3: superoxide dismutase 3; SP-1: specificity protein-1; SUV39H1: suppressor
    of variegation 3-9 homolog 1; SUV420H2: suppressor of variegation 4-20 homolog
    2; TxnIP: thioredoxin-interacting protein).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB1
  - KMT5C
  - TUBA4A
  - H2AC18
  - H2AC20
  - TUBA3D
  - H2BC21
  - SUV39H1
  - SOD2
  - SOD3
  - NOX4
  - KDM5A
  - EZH2
  - NOS2
  - ISYNA1
  - KMT5AP1
  - SETD7
  - SP1
  - PSG1
  - DAND5
  - KEAP1
  - MMP9
  - TXNIP
  - PAX6
  - COX2
  - PTGS2
  - MTCO2P12
---
